MCID: NRV004
MIFTS: 31

Nerve Compression Syndrome

Categories: Neuronal diseases

Aliases & Classifications for Nerve Compression Syndrome

MalaCards integrated aliases for Nerve Compression Syndrome:

Name: Nerve Compression Syndrome 12 15 73
Entrapment Neuropathies 55 73
Hereditary Liability to Pressure Palsies 73
Peripheral Nerve Entrapment Syndrome 12
Nerve Compression Syndromes 44
Compression Neuropathy 12
Entrapment Neuropathy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:573
MeSH 44 D009408
NCIt 50 C27221
SNOMED-CT 68 45781009

Summaries for Nerve Compression Syndrome

MalaCards based summary : Nerve Compression Syndrome, also known as entrapment neuropathies, is related to tarsal tunnel syndrome and al amyloidosis, and has symptoms including neuralgia An important gene associated with Nerve Compression Syndrome is PSMD9 (Proteasome 26S Subunit, Non-ATPase 9). The drugs Prednisolone and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include testes.

Wikipedia : 76 Nerve compression syndrome or compression neuropathy, also known as entrapment neuropathy, is a medical... more...

Related Diseases for Nerve Compression Syndrome

Diseases related to Nerve Compression Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 82)
# Related Disease Score Top Affiliating Genes
1 tarsal tunnel syndrome 32.1 B2M NOTCH1 TTR
2 al amyloidosis 29.8 B2M TTR
3 peripheral nervous system disease 29.7 ARHGEF10 PSMD9 TTR
4 carpal tunnel syndrome 29.5 B2M COL5A1 PSMD9 TTR
5 neuropathy, hereditary, with liability to pressure palsies 11.2
6 osteopetrosis, autosomal dominant 2 11.0
7 osteopetrosis, autosomal recessive 1 11.0
8 osteopetrosis, autosomal recessive 2 11.0
9 osteopetrosis, autosomal recessive 5 11.0
10 osteopetrosis, autosomal recessive 3 11.0
11 osteopetrosis, autosomal dominant 1 11.0
12 osteopetrosis, autosomal recessive 4 11.0
13 osteopetrosis, autosomal recessive 6 11.0
14 osteopetrosis, autosomal recessive 7 11.0
15 osteopetrosis 11.0
16 uremic neuropathy 10.2 ARHGEF10 B2M
17 median rhomboid glossitis 10.2 B2M TTR
18 amyloid tumor 10.1 B2M TTR
19 hereditary amyloidosis 10.1 B2M TTR
20 amyloidosis aa 10.1 B2M TTR
21 tibial neuropathy 10.1 B2M NOTCH1 TTR
22 retinitis pigmentosa 7 10.0 B2M TTR
23 optic disk drusen 10.0 GALNT3 NOTCH1
24 amyloidosis, familial visceral 10.0 B2M TTR
25 radiculopathy 10.0
26 meralgia paresthetica 10.0
27 osteochondroma 10.0
28 popliteal cyst 9.9
29 inguinal hernia 9.8
30 neuritis 9.8
31 tenosynovitis 9.8
32 amyotrophic lateral sclerosis 1 9.8
33 charcot-marie-tooth disease, demyelinating, type 1b 9.8
34 rheumatoid arthritis 9.8
35 muscle hypertrophy 9.8
36 arthritis 9.8
37 cerebral palsy 9.8
38 charcot-marie-tooth disease 9.8
39 diabetes mellitus 9.8
40 intermittent claudication 9.8
41 multifocal motor neuropathy 9.8
42 spastic cerebral palsy 9.8
43 focal hand dystonia 9.8
44 tooth disease 9.8
45 mononeuropathy 9.8
46 ulnar nerve lesion 9.8
47 hypermobility syndrome 9.8
48 hyperostosis 9.8
49 lateral sclerosis 9.8
50 thoracic outlet syndrome 9.8

Graphical network of the top 20 diseases related to Nerve Compression Syndrome:



Diseases related to Nerve Compression Syndrome

Symptoms & Phenotypes for Nerve Compression Syndrome

UMLS symptoms related to Nerve Compression Syndrome:


neuralgia

Drugs & Therapeutics for Nerve Compression Syndrome

Drugs for Nerve Compression Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 214)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 50-24-8 5755
2
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 302-25-0
3
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
4
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 2921-57-5
5
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 83-43-2 6741
6
Bupivacaine Approved, Investigational Phase 4,Phase 1,Not Applicable,Early Phase 1 2180-92-9, 38396-39-3 2474
7
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 124-94-7 31307
8
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
9
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
10
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
11
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3 56-12-2 119
12
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 175805 71273
13
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
14
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
15
Ibuprofen Approved Phase 4,Phase 2 15687-27-1 3672
16
Hydrocodone Approved, Illicit, Investigational Phase 4 125-29-1 5284569
17 tannic acid Approved Phase 4
18
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
19
Vancomycin Approved Phase 4 1404-90-6 14969 441141
20
Cefazolin Approved Phase 4 25953-19-9 656510 33255
21
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 2 76-42-6 5284603
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 59-30-3 6037
23
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 11103-57-4, 68-26-8 445354
24
Prednisolone hemisuccinate Experimental Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 2920-86-7
25 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
26 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Not Applicable
27 Hormone Antagonists Phase 4,Phase 2,Phase 3,Not Applicable
28 Prednisolone acetate Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
29 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3,Not Applicable
30 Autonomic Agents Phase 4,Phase 2,Phase 3,Not Applicable
31 Hormones Phase 4,Phase 2,Phase 3,Not Applicable
32 Neuroprotective Agents Phase 4,Phase 2,Phase 3,Not Applicable
33 Antiemetics Phase 4,Phase 2,Phase 3,Not Applicable
34 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3,Not Applicable
35 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
36 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Not Applicable
37 glucocorticoids Phase 4,Phase 2,Phase 3,Not Applicable
38 Methylprednisolone acetate Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
39 Analgesics, Non-Narcotic Phase 4,Phase 2,Not Applicable
40 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Anesthetics, Local Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
42 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
43 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
44 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
45 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
46 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
47 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Not Applicable
48 Anticonvulsants Phase 4,Phase 3,Not Applicable
49 Antimanic Agents Phase 4,Phase 3,Not Applicable
50 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 299)
# Name Status NCT ID Phase Drugs
1 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
2 Myofascial Release on Electrophysiological Measures of Pregnant Women With CTS Completed NCT03802448 Phase 4
3 Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome Completed NCT02652390 Phase 4 Methylprednisolone 80 mg;Methylprednisolone 40 mg
4 Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries Completed NCT02313675 Phase 4 Acetaminophen;Ketorolac Tromethamine;Saline
5 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
6 Bupivacaine Versus Lidocaine Local Anesthesia Completed NCT01751347 Phase 4 Bupivacaine;Lidocaine
7 Length of Post Operative Dressing After Carpal Tunnel Release Completed NCT01310218 Phase 4
8 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
9 Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters Completed NCT00678314 Phase 4 Ropivacaine 0.2%;Ropivacaine 0.75%;Normal saline
10 Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia Completed NCT00851513 Phase 4 Lidocaine;Depmedrol
11 Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome Completed NCT00277563 Phase 4
12 Onset and Duration of Forearm Nerve Blockade Recruiting NCT03649763 Phase 4 Lidocaine;Bupivacaine;Lidocaine
13 Narcotic vs. Non-narcotic Pain Study Protocol Recruiting NCT01974609 Phase 4 Narcotic;non-narcotic
14 Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration Active, not recruiting NCT03196817 Phase 4 betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%
15 Injection Versus Splinting in Carpal Tunnel Syndrome Active, not recruiting NCT02038452 Phase 4 Depo-Medrone
16 Preoperative Antibiotics for Carpal Tunnel Release Surgery Not yet recruiting NCT03432858 Phase 4 Vancomycin;Cefazolin;Saline Solution
17 Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS Not yet recruiting NCT03792945 Phase 4 local injection
18 Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Terminated NCT02029235 Phase 4 Acetaminophen/Ibuprofen;Acetaminophen/Hydrocodone
19 Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery Terminated NCT01588158 Phase 4 Acetaminophen;Vicodin
20 Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain Withdrawn NCT02748395 Phase 4 Triamcinolone;Lidocaine
21 Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Unknown status NCT01289704 Phase 2, Phase 3
22 Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome Unknown status NCT02870673 Phase 2, Phase 3 SHINCORT;XYLOCAINE
23 Carpal Tunnel Syndrome Release Using PSU Retractor Unknown status NCT01017471 Phase 3
24 Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Completed NCT02579759 Phase 3 PXT3003 dose 1;PXT3003 dose 2;placebo
25 High Dose Ascorbic Acid Treatment of CMT1A Completed NCT00484510 Phase 2, Phase 3 Ascorbic acid (Vitamin C);placebo
26 Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Completed NCT02141035 Phase 2, Phase 3 Acetyl-l-carnitine;placebo
27 Sonographic Examination Cubital Tunnel Release Completed NCT02739945 Phase 3
28 Sonography-guided Steroid Injection for Carpal Tunnel Syndrome Completed NCT02575729 Phase 3 betamethasone
29 Preoperative Gabapentine for Carpal Tunnel Completed NCT01632215 Phase 3 Gabapentine
30 Steroid Injection Treatment of Carpal Tunnel Syndrome Completed NCT00806871 Phase 2, Phase 3 Methylprednisolone 40 mg;Methylprednisolone 80 mg;Sodium chloride
31 Gabapentin for Carpal Tunnel Syndrome Completed NCT00137735 Phase 3 Gabapentin
32 Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia Completed NCT02604186 Phase 2, Phase 3
33 Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Completed NCT00007020 Phase 3 Cholic Acids
34 Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Recruiting NCT03023540 Phase 3 PXT3003
35 Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity Recruiting NCT03746522 Phase 3 Setmelanotide;Placebos
36 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
37 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Enrolling by invitation NCT03184584 Phase 2, Phase 3 PBI-4050
38 Erythropoietin Spinal Cord Compression Randomized Trial Terminated NCT00220675 Phase 2, Phase 3 Erythropoietin infusion
39 NeuroPath Comparative Validation Study Plan Terminated NCT00393549 Phase 3
40 A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Terminated NCT00209560 Phase 3 fospropofol disodium
41 Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome Terminated NCT00266214 Phase 3 lidocaine patch 5%
42 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Unknown status NCT02967679 Phase 1, Phase 2 MD1003
43 Carpal Tunnel Syndrome and Static Magnetic Field Therapy Unknown status NCT00521495 Phase 2
44 Carpal Tunnel Syndrome Treated With 830nm Diode Laser Unknown status NCT00514462 Phase 1, Phase 2
45 Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Completed NCT00541164 Phase 1, Phase 2 Coenzyme Q10
46 Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Completed NCT02561702 Phase 2 Mexiletine
47 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed NCT01401257 Phase 2 PXT3003 Low dose;PXT3003 Intermediate Dose;PXT3003 High Dose
48 Ascorbic Acid Treatment in CMT1A Trial (AATIC) Completed NCT00271635 Phase 2 Placebo;ascorbic acid
49 The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome Completed NCT00634738 Phase 1, Phase 2
50 L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 Completed NCT01733407 Phase 1, Phase 2 L-serine;placebo

Search NIH Clinical Center for Nerve Compression Syndrome

Cochrane evidence based reviews: nerve compression syndromes

Genetic Tests for Nerve Compression Syndrome

Anatomical Context for Nerve Compression Syndrome

MalaCards organs/tissues related to Nerve Compression Syndrome:

41
Testes

Publications for Nerve Compression Syndrome

Articles related to Nerve Compression Syndrome:

(show top 50) (show all 127)
# Title Authors Year
1
Tumour-like giant nerves in entrapment neuropathies. ( 29353184 )
2018
2
Entrapment Neuropathies: Challenging Common Beliefs With Novel Evidence. ( 29385943 )
2018
3
Sensory profiles are comparable in patients with distal and proximal entrapment neuropathies, while the pain experience differs. ( 29526115 )
2018
4
Peripheral nerve injuries in the pediatric population: a review of the literature. Part II: entrapment neuropathies. ( 30209596 )
2018
5
MR Imaging of Entrapment Neuropathies of the Lower Extremity. ( 30322495 )
2018
6
Redo Microvascular Decompression in a Patient of Resistant Cochleovestibular Nerve Compression Syndrome. ( 29114297 )
2017
7
Carpal Tunnel Syndrome and Other Entrapment Neuropathies. ( 29218119 )
2017
8
Negative Neurodynamic Tests Do Not Exclude Neural Dysfunction in Patients With Entrapment Neuropathies. ( 27449322 )
2017
9
Common Entrapment Neuropathies. ( 28375915 )
2017
10
Cochleovestibular nerve compression syndrome due to intrameatal Anterior Inferior Cerebellar Artery loop: synthesis of best evidence for clinical decisions. ( 27647022 )
2016
11
Resolution of intractable retching following mobilization of a dolichoectatic vertebral artery: case report of a unique brainstem-cranial nerve compression syndrome. ( 27767394 )
2016
12
Uridine monophosphate, folic acid and vitamin B12 in patients with symptomatic peripheral entrapment neuropathies. ( 26679082 )
2016
13
Diagnostic accuracy of nerve ultrasound in hereditary and sporadic non-entrapment neuropathies. ( 27502085 )
2016
14
Entrapment neuropathies in diabetes mellitus. ( 27660694 )
2016
15
Electrodiagnostic approach in entrapment neuropathies of the median and ulnar nerves. ( 26150869 )
2015
16
Entrapment Neuropathies of the Foot and Ankle. ( 26409596 )
2015
17
Treatment of low back pain in patients with vertebral compression fractures and superior cluneal nerve entrapment neuropathies. ( 26693392 )
2015
18
Focal and entrapment neuropathies. ( 25410212 )
2014
19
Assessment of the utility of ultrasonography with high-frequency transducers in the diagnosis of entrapment neuropathies. ( 26674099 )
2014
20
Entrapment neuropathies of the lower extremity. ( 23542774 )
2013
21
Entrapment neuropathies. ( 23642716 )
2013
22
Neuromuscular ultrasound in common entrapment neuropathies. ( 23681885 )
2013
23
Compression and entrapment neuropathies. ( 23931789 )
2013
24
Reappraising entrapment neuropathies--mechanisms, diagnosis and management. ( 24008054 )
2013
25
Electrophysciological analysis of entrapment neuropathies developed in acute and subacute period in paretic and non-paretic extremities in patients with stroke. ( 23866507 )
2012
26
Ultrasound assessment of selected peripheral nerves pathologies. Part II: Entrapment neuropathies of the lower limb. ( 26673938 )
2012
27
Entrapment neuropathies in chronic stroke patients. ( 22353993 )
2012
28
Entrapment neuropathies of the shoulder. ( 22469409 )
2012
29
Entrapment neuropathies in the upper and lower limbs: anatomy and MRI features. ( 23125929 )
2012
30
Anterior interosseous nerve compression syndrome: is there a role for endoscopy? ( 21786008 )
2011
31
Hypertrophic abductor hallucis muscle with nerve compression syndrome. ( 21381535 )
2010
32
A commentary on the relation between putative central plastic changes and sensory symptoms in peripheral entrapment neuropathies. ( 20403665 )
2010
33
MR imaging of entrapment neuropathies of the lower extremity. Part 1. The pelvis and hip. ( 20631364 )
2010
34
MR imaging of entrapment neuropathies of the lower extremity. Part 2. The knee, leg, ankle, and foot. ( 20631365 )
2010
35
What's new in the diagnosis and treatment of peripheral nerve entrapment neuropathies. ( 20816274 )
2010
36
Entrapment neuropathies I: upper limb (carpal tunnel excluded). ( 21072726 )
2010
37
Entrapment neuropathies II: carpal tunnel syndrome. ( 21072727 )
2010
38
Entrapment neuropathies III: lower limb. ( 21072728 )
2010
39
Impaired laryngeal mobility and entrapment neuropathies. ( 21077411 )
2010
40
Clinical relevance of neuromuscular findings and abnormal movement patterns: a comparison between focal hand dystonia and upper extremity entrapment neuropathies. ( 19278824 )
2009
41
Development of entrapment neuropathies in acute stroke patients. ( 19053953 )
2009
42
Prevalence and risk factors for upper extremity entrapment neuropathies in polio survivors. ( 19197565 )
2009
43
Invited commentary. Carpal tunnel syndrome is one of the most common peripheral entrapment neuropathies and is associated with substantial direct medical costs and with economic costs in terms of man day loss and possible continuing disability. ( 19777684 )
2009
44
Macrodystrophia lipomatosa with multiple entrapment neuropathies: a case report. ( 18322862 )
2008
45
What's new in common upper extremity entrapment neuropathies. ( 19010282 )
2008
46
Controversial entrapment neuropathies. ( 19010284 )
2008
47
Differential diagnosis of cervical nerve compression syndrome of the external intervertebral foramen. ( 24557672 )
2007
48
A rare genetic disorder in the differential diagnosis of the entrapment neuropathies: hereditary neuropathy with liability to pressure palsies. ( 16601541 )
2006
49
Diagnosing entrapment neuropathies: probes and magnets instead of electrodes and needles? ( 16368263 )
2006
50
Entrapment neuropathies of the shoulder and elbow in the athlete. ( 16798138 )
2006

Variations for Nerve Compression Syndrome

Expression for Nerve Compression Syndrome

Search GEO for disease gene expression data for Nerve Compression Syndrome.

Pathways for Nerve Compression Syndrome

GO Terms for Nerve Compression Syndrome

Sources for Nerve Compression Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....